Answers are grounded in this paper and cite their sources.
Lipopolysaccharide (LPS) challenge studies in animal models and healthy volunteers are widely used to investigate inflammatory cytokine responses and evaluate anti-inflammatory therapies. Quantitative interspecies differences complicate translation of anti-inflammatory responses and their pharmacological modulation from animals to humans. This study aimed to demonstrate how a model-based framework can be used to characterize LPS-induced cytokine responses and quantify interspecies differences towards improving animal-to-human translation. To this end, we utilized data from published LPS challenge studies in humans, pigs, and rats, from which study characteristics, LPS doses, and concentration-time profiles of interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) were extracted. For each species, cytokine dynamics were characterized using a kinetic-pharmacodynamic (K-PD) model with a turnover model structure where LPS stimulated cytokine production. Delay differential equations (DDEs) were used to account for delayed cytokine production. The model framework adequately described species-specific IL-6 and TNF-α responses and enabled quantitative comparison of LPS effects on cytokine production. Overall, this study demonstrates how LPS challenge data can be integrated into a quantitative framework for investigating interspecies differences. The framework provides a foundation for quantitative translation of inflammatory responses from animal models to humans.
No takes yet. Share an insight, caveat, or question.
Kreeke et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: